196 related articles for article (PubMed ID: 9252984)
21. Increased cortical nitric oxide release after phencyclidine administration.
Pålsson E; Finnerty N; Fejgin K; Klamer D; Wass C; Svensson L; Lowry J
Synapse; 2009 Dec; 63(12):1083-8. PubMed ID: 19642219
[TBL] [Abstract][Full Text] [Related]
22. Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.
McAllister KA; Mar AC; Theobald DE; Saksida LM; Bussey TJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):3883-97. PubMed ID: 26194915
[TBL] [Abstract][Full Text] [Related]
23. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
[TBL] [Abstract][Full Text] [Related]
24. Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex.
Hajszan T; Leranth C; Roth RH
Biol Psychiatry; 2006 Sep; 60(6):639-44. PubMed ID: 16814748
[TBL] [Abstract][Full Text] [Related]
25. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction.
Mizoguchi K; Yuzurihara M; Ishige A; Sasaki H; Chui DH; Tabira T
J Neurosci; 2000 Feb; 20(4):1568-74. PubMed ID: 10662846
[TBL] [Abstract][Full Text] [Related]
26. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Jodo E
J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Jentsch JD; Taylor JR; Redmond DE; Elsworth JD; Youngren KD; Roth RH
Psychopharmacology (Berl); 1999 Feb; 142(1):78-84. PubMed ID: 10102786
[TBL] [Abstract][Full Text] [Related]
28. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Elsworth JD; Groman SM; Jentsch JD; Valles R; Shahid M; Wong E; Marston H; Roth RH
Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
[TBL] [Abstract][Full Text] [Related]
29. Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress.
Elsworth JD; Morrow BA; Roth RH
Synapse; 2001 Nov; 42(2):80-3. PubMed ID: 11574943
[TBL] [Abstract][Full Text] [Related]
30. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
[TBL] [Abstract][Full Text] [Related]
31. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
32. Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
Boyce PJ; Finlay JM
Brain Res Dev Brain Res; 2005 May; 156(2):167-75. PubMed ID: 16099303
[TBL] [Abstract][Full Text] [Related]
33. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.
Noda Y; Kamei H; Mamiya T; Furukawa H; Nabeshima T
Neuropsychopharmacology; 2000 Oct; 23(4):375-87. PubMed ID: 10989264
[TBL] [Abstract][Full Text] [Related]
34. Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex.
Castner SA; Vosler PS; Goldman-Rakic PS
Biol Psychiatry; 2005 Apr; 57(7):743-51. PubMed ID: 15820231
[TBL] [Abstract][Full Text] [Related]
35. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
36. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
Balla A; Koneru R; Smiley J; Sershen H; Javitt DC
Neuropsychopharmacology; 2001 Aug; 25(2):157-64. PubMed ID: 11425499
[TBL] [Abstract][Full Text] [Related]
37. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
38. Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.
Jentsch JD; Verrico CD; Le D; Roth RH
Neurosci Lett; 1998 May; 246(3):169-72. PubMed ID: 9792619
[TBL] [Abstract][Full Text] [Related]
39. Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity.
Jentsch JD; Roth RH; Taylor JR
Biol Psychiatry; 2000 Sep; 48(5):415-24. PubMed ID: 10978725
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia.
Jentsch JD; Elsworth JD; Taylor JR; Redmond DE; Roth RH
Adv Pharmacol; 1998; 42():810-4. PubMed ID: 9328021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
